Story thread · 2 reports / 1 sources
Barfresh outlines $23M-$26M FY2026 revenue outlook while targeting partial commissioning of Defiance plant by end of 2026
seekingalpha.com · 3h
First report: Biostem raises 2026 revenue outlook to $26M-$29M while targeting manufacturing transfer in H1 2027 — seekingalpha.com, 2d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.